VIOL Medical and BENEV Donate USD 150,000 to Support Breast Cancer Patients

Donated approximately USD 150,000 raised through the Casino Night raffle to a breast cancer support foundation

[VIOL Medical CEO Eunchun Lee poses for a commemorative photo with key attendees at the ABAM Casino Night raffle event held on July 7 (local time) in Utah, U.S. (From left: Ethan Min, CEO of BENEV; Eunchun Lee CEO of VIOL; Dr. Kiya Movassaghi, President of The Aesthetic Society; and his spouse./Photo courtesy of VIOL Medical)]

VIOL Medical, a global leader in energy-based medical devices (EBD), announced that it joined its U.S. partner BENEV in a charity event during the American Brazilian Aesthetic Meeting (ABAM), contributing approximately USD 150,000 raised through the event to support breast cancer patients.
 
Founded in 2009, VIOL Medical develops and supplies microneedle RF-based medical devices and continues to strengthen its technological leadership in the aesthetic medical field. Its flagship products include Sylfirm X, CellinU, and DUOTITE, and the company is steadily expanding its portfolio of devices for aesthetic treatments worldwide.
 
VIOL Medical has established a strategic partnership with BENEV, a U.S.-based medical aesthetics company, collaborating on distribution and clinical education initiatives in the U.S. market centered on Sylfirm X. Through ongoing scientific exchange and physician training programs, the two companies continue to strengthen their presence in the market.
 
VIOL Medical and BENEV participated in the American Brazilian Aesthetic Meeting (ABAM), held from February 5 to 8 in Park City, Utah. ABAM is an internationally recognized conference that brings together leading dermatologists, plastic surgeons, and medical aesthetics professionals from the United States and Brazil to share the latest treatment trends, clinical insights, and medical device innovations. During the event, the two companies highlighted the technological advantages of Sylfirm X to attending physicians.
 

In addition, approximately USD 150,000 raised through the Casino Night Raffle held on February 7 during the conference was donated to a U.S.-based foundation supporting breast cancer patients. The funds will be used to support patient care and related charitable initiatives.
 

[Image by VIOL]

The donation is particularly meaningful as it reflects the global embodiment of VIOL Medical's corporate mission, “Victory of Life,” which seeks to enhance quality of life through the convergence of biotechnology and electronic engineering in medical devices.
 
“We are honored to engage with medical professionals at an international conference and to contribute to a meaningful initiative supporting patients,” said Eunchun Lee, CEO of VIOL Medical. “We will continue to advance medical technology that contributes to society beyond treatment.” /End
  

정현식 기자